Related
Case study - Treefrog
TreeFrog Therapeutics is a French biotechnology company specialized in cell therapy. In April 2022, it announced the opening of a lab in Kobe, Japan, with the aim of establishing strategic alliances with key academic and industrial players in the field of regenerative medicine.
Webinar 97: Update on cell technology, cell therapy, tissue engineering and gene therapy in Japan
20
Jun
2017
20-06-17 | 10:30 - 11:30 AM CETWill Japan take the lead in regenerative medicine, a multi-billion € business? 

EU-Japan Centre's News

More
The Centre quarterly newsletter, June 2026 issue, is now available. In this issue:   Last chance…
The Belgian-Luxembourg Chamber of Commerce in Japan (BLCCJ) is organizing the 13th edition of the…
Call for Applications: WCM October 2026 – 56th edition Applications are now open for the 56th…
The EU Japan Centre is releasing a weekly press review covering Japan's economic and business…
The EU Japan Centre is releasing a weekly press review covering Japan's economic and business…

Events

More
Japan
16/03/2026 - 19/03/2026
  The next mission will take place from 23-26 March, 2027 Planned application period: September - early November 2026   Please note that this page is still under construction; content relating to…
07/07/2026
EU-Japan Centre for Industrial Cooperation Minerva Policy SeminarChallenges Confronting the Hydrogen Strategies of the EU and Japan and Efforts to Strengthen the Japan–EU Partnership Tuesday 7…
Time in Brussels
-
Time in Tokyo
-
Exchange rate
1€ = 184,231 JPY